Capstone Therapeutics's total assets for Q1 2025 were $52.21M, an increase of 10.56% from the previous quarter. CAPS total liabilities were $25.24M for the fiscal quarter, a -49.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.